NCT05659186 2022-12-21PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid CancerWest China HospitalPhase 2 Unknown20 enrolled
NCT04309136 2021-04-01Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid CancerFudan UniversityPhase 2 Unknown13 enrolled